240
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Effects of extremely low-frequency magnetotherapy on proliferation of human dermal fibroblasts

, , , , , , , , & show all
Pages 343-352 | Received 14 Jul 2015, Accepted 11 Oct 2015, Published online: 02 Jun 2016
 

ABSTRACT

Extremely low-frequency electromagnetic fields (ELF-EMFs) applied in magnetotherapy have frequency lower than 100 Hz and magnetic field intensity ranging from 0.1 to 20 mT. For many years, the use of magnetotherapy in clinics has been increasing because of its beneficial effects in many processes, e.g., skin diseases, inflammation and bone disorders. However, the understanding of the microscopic mechanisms governing such processes is still lacking and the results of the studies on the effects of ELF-EMFs are controversial because effects derive from different conditions and from intrinsic responsiveness of different cell types.In the present study, we studied the biological effects of 1.5 h exposure of human dermal fibroblasts to EMFs with frequencies of 5 and 50 Hz and intensity between 0.25 and 1.6 mT. Our data showed that the magnetic treatment did not produce changes in cell viability, but gave evidence of a sizeable decrease in proliferation at 24 h after treatment. In addition, immunofluorescence experiments displayed an increase in tubulin expression that could foreshadow changes in cell motility or morphology. The decrease in proliferation with unchanged viability and increase in tubulin expression could be consistent with the triggering of a transdifferentiation process after the exposure to ELF-EMFs.

Acknowledgments

The authors thank Dr. Lucio Zaghetto and ASALaser (Vicenza, Italy) for the collaboration and scientific cooperation. Alessandro Lascialfari, Marco Alquati, Maurizio Enrico Corti and Samuele Sanna thank the Italian FIRB “Rete Integrata per la NAnoMEdicina (RINAME)” project.

Declaration of interest

The authors declare that there is no conflict of interests regarding the publication of this paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.